Separate group would ensure strong, effective leadership for urologyprogramWashington-Frustrated with a lack of progress at the NationalInstitute of Diabetes and Digestive and Kidney Diseases (NIDDK), AUA isnow pushing for creation of a separate urology division that would give"strong and effective leadership for the urology program" at theNational Institutes of Health.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.